Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 364

1.

Paying for CAR-T Therapy Amidst Limited Health System Resources.

Campbell JD, Whittington MD.

J Clin Oncol. 2019 Jun 3:JCO1901113. doi: 10.1200/JCO.19.01113. [Epub ahead of print] No abstract available.

PMID:
31157580
2.

The promise of Immuno-oncology: implications for defining the value of cancer treatment.

Kaufman HL, Atkins MB, Subedi P, Wu J, Chambers J, Joseph Mattingly T 2nd, Campbell JD, Allen J, Ferris AE, Schilsky RL, Danielson D, Lichtenfeld JL, House L, Selig WKD.

J Immunother Cancer. 2019 May 17;7(1):129. doi: 10.1186/s40425-019-0594-0.

3.

scruff: an R/Bioconductor package for preprocessing single-cell RNA-sequencing data.

Wang Z, Hu J, Johnson WE, Campbell JD.

BMC Bioinformatics. 2019 May 2;20(1):222. doi: 10.1186/s12859-019-2797-2.

4.

Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".

McQueen RB, Whittington MD, Chapman RH, Kumar VM, Campbell JD.

Pharmacoeconomics. 2019 Jul;37(7):963-964. doi: 10.1007/s40273-019-00802-8. No abstract available.

PMID:
31044348
5.

The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma.

Tice JA, Campbell JD, Synnott PG, Walsh JME, Kumar VM, Whittington M, Adair E, Rind D, Pearson SD.

J Manag Care Spec Pharm. 2019 May;25(5):510-514. doi: 10.18553/jmcp.2019.25.5.510.

6.

Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions.

Beane JE, Mazzilli SA, Campbell JD, Duclos G, Krysan K, Moy C, Perdomo C, Schaffer M, Liu G, Zhang S, Liu H, Vick J, Dhillon SS, Platero SJ, Dubinett SM, Stevenson C, Reid ME, Lenburg ME, Spira AE.

Nat Commun. 2019 Apr 23;10(1):1856. doi: 10.1038/s41467-019-09834-2.

7.

1,25-Dihydroxyvitamin D3 Restrains CD4+ T Cell Priming Ability of CD11c+ Dendritic Cells by Upregulating Expression of CD31.

Saul L, Mair I, Ivens A, Brown P, Samuel K, Campbell JDM, Soong DY, Kamenjarin N, Mellanby RJ.

Front Immunol. 2019 Mar 28;10:600. doi: 10.3389/fimmu.2019.00600. eCollection 2019.

8.

The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies.

Campbell JD, Perry R, Papadopoulos NG, Krishnan J, Brusselle G, Chisholm A, Bjermer L, Thomas M, van Ganse E, van den Berge M, Quint J, Price D, Roche N.

Clin Transl Allergy. 2019 Mar 27;9:21. doi: 10.1186/s13601-019-0256-9. eCollection 2019.

9.

Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.

Roche N, Campbell JD, Krishnan JA, Brusselle G, Chisholm A, Bjermer L, Thomas M, van Ganse E, van den Berge M, Christoff G, Quint J, Papadopoulos NG, Price D.

Clin Transl Allergy. 2019 Mar 27;9:20. doi: 10.1186/s13601-019-0255-x. eCollection 2019.

10.

Meta-analysis of randomized controlled trials that assess the efficacy of low-intensity shockwave therapy for the treatment of erectile dysfunction.

Campbell JD, Trock BJ, Oppenheim AR, Anusionwu I, Gor RA, Burnett AL.

Ther Adv Urol. 2019 Mar 29;11:1756287219838364. doi: 10.1177/1756287219838364. eCollection 2019 Jan-Dec.

11.

Is Prevalence of Atherosclerotic Risk Factors Increasing Among Young Adults? It Depends on How You Ask.

Leppert MH, Poisson SN, Sillau SH, Campbell JD, Ho PM, Burke JF.

J Am Heart Assoc. 2019 Mar 19;8(6):e010883. doi: 10.1161/JAHA.118.010883.

12.

Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma.

Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD.

JAMA Netw Open. 2019 Feb 1;2(2):e190035. doi: 10.1001/jamanetworkopen.2019.0035.

13.

Long-term follow up after third party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease.

Kazi S, Mathur A, Wilkie G, Cheal K, Battle R, McGowan N, Fraser N, Hargreaves E, Turner D, Campbell JDM, Turner M, Vickers MA.

Haematologica. 2019 Feb 21. pii: haematol.2018.207548. doi: 10.3324/haematol.2018.207548. [Epub ahead of print]

14.

Validation of an algorithm for identifying MS cases in administrative health claims datasets.

Culpepper WJ, Marrie RA, Langer-Gould A, Wallin MT, Campbell JD, Nelson LM, Kaye WE, Wagner L, Tremlett H, Chen LH, Leung S, Evans C, Yao S, LaRocca NG; United States Multiple Sclerosis Prevalence Workgroup (MSPWG).

Neurology. 2019 Mar 5;92(10):e1016-e1028. doi: 10.1212/WNL.0000000000007043. Epub 2019 Feb 15.

15.

The prevalence of MS in the United States: A population-based estimate using health claims data.

Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG; US Multiple Sclerosis Prevalence Workgroup.

Neurology. 2019 Mar 5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15.

16.

Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries.

Németh B, Molnár A, Bozóki S, Wijaya K, Inotai A, Campbell JD, Kaló Z.

J Comp Eff Res. 2019 Mar;8(4):195-204. doi: 10.2217/cer-2018-0102. Epub 2019 Feb 15.

17.

Allogeneic Ex Vivo Expanded Corneal Epithelial Stem Cell Transplantation: A Randomized Controlled Clinical Trial.

Campbell JDM, Ahmad S, Agrawal A, Bienek C, Atkinson A, Mcgowan NWA, Kaye S, Mantry S, Ramaesh K, Glover A, Pelly J, MacRury C, MacDonald M, Hargreaves E, Barry J, Drain J, Cuthbertson B, Nerurkar L, Downing I, Fraser AR, Turner ML, Dhillon B.

Stem Cells Transl Med. 2019 Apr;8(4):323-331. doi: 10.1002/sctm.18-0140. Epub 2019 Jan 28.

18.

Hydro-Jet Dissection of the Cavernous Nerves Preserves Erection Function in a Radical Prostatectomy Animal Model.

Campbell JD, Alenezi H, DeYoung LX, Brock GB, Pautler SE.

Sex Med. 2019 Mar;7(1):104-110. doi: 10.1016/j.esxm.2018.11.006. Epub 2019 Jan 21.

19.

Ten quick tips for sharing open genomic data.

Brown AV, Campbell JD, Assefa T, Grant D, Nelson RT, Weeks NT, Cannon SB.

PLoS Comput Biol. 2018 Dec 27;14(12):e1006472. doi: 10.1371/journal.pcbi.1006472. eCollection 2018 Dec.

20.

Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.

Whittington MD, McQueen RB, Ollendorf DA, Chapman RH, Kumar VM, Synnott PG, Agboola F, Campbell JD.

J Manag Care Spec Pharm. 2019 Jan;25(1):80-87. doi: 10.18553/jmcp.2019.25.1.080. Erratum in: J Manag Care Spec Pharm. 2019 Jun;25(6):726.

21.

Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells.

Kell SA, Kachura MA, Renn A, Traquina P, Coffman RL, Campbell JD.

Int Immunopharmacol. 2019 Jan;66:296-308. doi: 10.1016/j.intimp.2018.11.019. Epub 2018 Nov 29.

PMID:
30502651
22.

Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy.

Whittington MD, Ollendorf DA, Campbell JD.

JAMA Oncol. 2018 Dec 1;4(12):1784-1785. doi: 10.1001/jamaoncol.2018.4625. No abstract available.

PMID:
30325984
23.

Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia.

Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD.

JAMA Pediatr. 2018 Dec 1;172(12):1161-1168. doi: 10.1001/jamapediatrics.2018.2530.

PMID:
30304407
24.

Flow cytometric assays for identity, safety and potency of cellular therapies.

Campbell JDM, Fraser AR.

Cytometry B Clin Cytom. 2018 Sep;94(5):569-579. doi: 10.1002/cyto.b.21735. Review.

PMID:
30240161
25.

Fair global drug pricing.

Campbell JD, Kaló Z.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):581-583. doi: 10.1080/14737167.2018.1524296. Epub 2018 Sep 28. No abstract available.

PMID:
30215535
26.

Update From the Advisory Committee on Immunization Practices.

O'Leary ST, Campbell JD, Kimberlin DW.

J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):270-274. doi: 10.1093/jpids/piy070.

PMID:
30113691
27.

Guidance toward the implementation of multicriteria decision analysis framework in developing countries.

Inotai A, Nguyen HT, Hidayat B, Nurgozhin T, Kiet PHT, Campbell JD, Németh B, Maniadakis N, Brixner D, Wijaya K, Kaló Z.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):585-592. doi: 10.1080/14737167.2018.1508345. Epub 2018 Aug 24.

PMID:
30092151
28.

Prices For Common Cardiovascular Drugs In The US Are Not Consistently Aligned With Value.

Campbell JD, Belozeroff V, Whittington MD, Rubin RJ, Raggi P, Briggs AH.

Health Aff (Millwood). 2018 Aug;37(8):1298-1305. doi: 10.1377/hlthaff.2018.0221.

PMID:
30080450
29.

Treatment patterns and related clinical consequences in adults with asthma.

Dilokthornsakul P, Thompson AM, Campbell JD.

J Asthma. 2019 Jul;56(7):739-747. doi: 10.1080/02770903.2018.1490749. Epub 2018 Aug 24.

PMID:
29972095
30.

Physiologic Preoperative Knee Hyperextension Is a Predictor of Failure in an Anterior Cruciate Ligament Revision Cohort: A Report From the MARS Group.

MARS Group, Cooper DE, Dunn WR, Huston LJ, Haas AK, Spindler KP, Allen CR, Anderson AF, DeBerardino TM, Lantz BBA, Mann B, Stuart MJ, Albright JP, Amendola AN, Andrish JT, Annunziata CC, Arciero RA, Bach BR Jr, Baker CL 3rd, Bartolozzi AR, Baumgarten KM, Bechler JR, Berg JH, Bernas GA, Brockmeier SF, Brophy RH, Bush-Joseph CA, Butler V JB, Campbell JD, Carey JL, Carpenter JE, Cole BJ, Cooper JM, Cox CL, Creighton RA, Dahm DL, David TS, Flanigan DC, Frederick RW, Ganley TJ, Garofoli EA, Gatt CJ Jr, Gecha SR, Giffin JR, Hame SL, Hannafin JA, Harner CD, Harris NL Jr, Hechtman KS, Hershman EB, Hoellrich RG, Hosea TM, Johnson DC, Johnson TS, Jones MH, Kaeding CC, Kamath GV, Klootwyk TE, Levy BA, Ma CB, Maiers GP 2nd, Marx RG, Matava MJ, Mathien GM, McAllister DR, McCarty EC, McCormack RG, Miller BS, Nissen CW, O'Neill DF, Owens BD, Parker RD, Purnell ML, Ramappa AJ, Rauh MA, Rettig AC, Sekiya JK, Shea KG, Sherman OH, Slauterbeck JR, Smith MV, Spang JT, Svoboda SJ, Taft TN, Tenuta JJ, Tingstad EM, Vidal AF, Viskontas DG, White RA, Williams JS Jr, Wolcott ML, Wolf BR, York JJ, Wright RW.

Am J Sports Med. 2018 Oct;46(12):2836-2841. doi: 10.1177/0363546518777732. Epub 2018 Jun 8.

PMID:
29882693
31.

Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations.

McQueen RB, Sheehan DN, Whittington MD, van Boven JFM, Campbell JD.

Pharmacoeconomics. 2018 Aug;36(8):957-971. doi: 10.1007/s40273-018-0658-x. Review.

PMID:
29736895
32.

Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.

Leppert MH, Poisson SN, Carroll JD, Thaler DE, Kim CH, Orjuela KD, Ho PM, Burke JF, Campbell JD.

Stroke. 2018 Jun;49(6):1443-1450. doi: 10.1161/STROKEAHA.117.020322. Epub 2018 May 2.

33.

Achieving high value care for all and the perverse incentives of 340B price agreements.

Whittington MD, Campbell JD, McQueen RB.

Neurol Clin Pract. 2018 Apr;8(2):148-152. doi: 10.1212/CPJ.0000000000000437.

34.

Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 and Type 2 Diabetes in England.

McQueen RB, Breton MD, Craig J, Holmes H, Whittington MD, Ott MA, Campbell JD.

J Diabetes Sci Technol. 2018 Sep;12(5):992-1001. doi: 10.1177/1932296818769098. Epub 2018 Apr 21.

35.

Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer.

Bell MA, Campbell JD, Joice G, Sopko NA, Burnett AL.

World J Mens Health. 2018 May;36(2):103-109. doi: 10.5534/wjmh.170007. Epub 2018 Mar 22. Review.

36.

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.

Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina AI, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou JH, Rustgi AK, Drill E, Shen R, Wong CK; Cancer Genome Atlas Research Network, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Peto M, Pickering CR, Chen Z, Van Waes C.

Cell Rep. 2018 Apr 3;23(1):194-212.e6. doi: 10.1016/j.celrep.2018.03.063.

37.

A Call for Open-Source Cost-Effectiveness Analysis.

McQueen RB, Padula WV, Campbell JD.

Ann Intern Med. 2018 Apr 3;168(7):528-529. doi: 10.7326/L17-0694. No abstract available.

PMID:
29610902
38.

Considerations for Cost-effectiveness Analysis of Curative Pediatric Therapies.

Whittington MD, McQueen RB, Campbell JD.

JAMA Pediatr. 2018 May 1;172(5):409-410. doi: 10.1001/jamapediatrics.2018.0049. No abstract available.

PMID:
29554182
39.

Voriconazole: Poor Oral Bioavailability and Possible Renal Toxicity in an Infant With Invasive Aspergillosis.

Walldorf JA, Kishk OA, Campbell JD, Lardieri AB.

J Pediatr Pharmacol Ther. 2018 Jan-Feb;23(1):54-58. doi: 10.5863/1551-6776-23.1.54.

40.

Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey.

Campbell JD, Whittington MD, Kim CH, VanderVeen GR, Knupp KG, Gammaitoni A.

Epilepsy Behav. 2018 Mar;80:152-156. doi: 10.1016/j.yebeh.2018.01.003. Epub 2018 Feb 2.

41.

The direct and indirect costs of Dravet Syndrome.

Whittington MD, Knupp KG, Vanderveen G, Kim C, Gammaitoni A, Campbell JD.

Epilepsy Behav. 2018 Mar;80:109-113. doi: 10.1016/j.yebeh.2017.12.034. Epub 2018 Feb 2.

PMID:
29414539
42.

Surgical Factors Associated With Male and Female Sexual Dysfunction After Radical Cystectomy: What Do We Know and How Can We Improve Outcomes?

Pederzoli F, Campbell JD, Matsui H, Sopko NA, Bivalacqua TJ.

Sex Med Rev. 2018 Jul;6(3):469-481. doi: 10.1016/j.sxmr.2017.11.003. Epub 2018 Jan 19. Review.

PMID:
29371143
43.

Journeying to the White Coat Ceremony: A description of the people, situations and experiences that inform student visions of the physician they hope to become.

Brown RM, Donaldson JF, Warne-Griggs MD, Bagby Stone S, Campbell JD, Hoffman KG.

J Med Educ Curric Dev. 2017 Sep 4;4:2382120517725506. doi: 10.1177/2382120517725506. eCollection 2017 Jan-Dec.

44.

Risk Factors and Predictors of Significant Chondral Surface Change From Primary to Revision Anterior Cruciate Ligament Reconstruction: A MOON and MARS Cohort Study.

MARS Group, Magnussen RA, Borchers JR, Pedroza AD, Huston LJ, Haas AK, Spindler KP, Wright RW, Kaeding CC, Allen CR, Anderson AF, Cooper DE, DeBerardino TM, Dunn WR, Lantz BA, Mann B, Stuart MJ, Albright JP, Amendola A, Andrish JT, Annunziata CC, Arciero RA, Bach BR Jr, Baker CL 3rd, Bartolozzi AR, Baumgarten KM, Bechler JR, Berg JH, Bernas GA, Brockmeier SF, Brophy RH, Bush-Joseph CA, Butler JB 5th, Campbell JD, Carey JL, Carpenter JE, Cole BJ, Cooper JM, Cox CL, Creighton RA, Dahm DL, David TS, Flanigan DC, Frederick RW, Ganley TJ, Garofoli EA, Gatt CJ Jr, Gecha SR, Giffin JR, Hame SL, Hannafin JA, Harner CD, Harris NL Jr, Hechtman KS, Hershman EB, Hoellrich RG, Hosea TM, Johnson DC, Johnson TS, Jones MH, Kamath GV, Klootwyk TE, Levy BA, Ma CB, Maiers GP 2nd, Marx RG, Matava MJ, Mathien GM, McAllister DR, McCarty EC, McCormack RG, Miller BS, Nissen CW, O'Neill DF, Owens BD, Parker RD, Purnell ML, Ramappa AJ, Rauh MA, Rettig AC, Sekiya JK, Shea KG, Sherman OH, Slauterbeck JR, Smith MV, Spang JT, Svoboda SJ, Taft TN, Tenuta JJ, Tingstad EM, Vidal AF, Viskontas DG, White RA, Williams JS Jr, Wolcott ML, Wolf BR, York JJ.

Am J Sports Med. 2018 Mar;46(3):557-564. doi: 10.1177/0363546517741484. Epub 2017 Dec 15.

PMID:
29244532
45.

Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation.

Dilokthornsakul P, Patidar M, Campbell JD.

Value Health. 2017 Dec;20(10):1329-1335. doi: 10.1016/j.jval.2017.06.014. Epub 2017 Aug 1.

46.

High-throughput Phenotyping of Lung Cancer Somatic Mutations.

Berger AH, Brooks AN, Wu X, Shrestha Y, Chouinard C, Piccioni F, Bagul M, Kamburov A, Imielinski M, Hogstrom L, Zhu C, Yang X, Pantel S, Sakai R, Watson J, Kaplan N, Campbell JD, Singh S, Root DE, Narayan R, Natoli T, Lahr DL, Tirosh I, Tamayo P, Getz G, Wong B, Doench J, Subramanian A, Golub TR, Meyerson M, Boehm JS.

Cancer Cell. 2017 Dec 11;32(6):884. doi: 10.1016/j.ccell.2017.11.008. No abstract available.

47.

Surgery in 2017: Moving towards successful penile transplantation programmes.

Campbell JD, Burnett AL.

Nat Rev Urol. 2018 Feb;15(2):75-76. doi: 10.1038/nrurol.2017.204. Epub 2017 Dec 5. No abstract available.

PMID:
29205201
48.

NetSig: network-based discovery from cancer genomes.

Horn H, Lawrence MS, Chouinard CR, Shrestha Y, Hu JX, Worstell E, Shea E, Ilic N, Kim E, Kamburov A, Kashani A, Hahn WC, Campbell JD, Boehm JS, Getz G, Lage K.

Nat Methods. 2018 Jan;15(1):61-66. doi: 10.1038/nmeth.4514. Epub 2017 Dec 4.

49.

First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-Tolerated.

Jackson S, Candia AF, Delaney S, Floettmann S, Wong C, Campbell JD, Kell S, Lum J, Hessel EM, Traquina P, McHale M, Robinson I, Bell J, Fuhr R, Keeling D, Coffman RL.

Clin Pharmacol Ther. 2018 Aug;104(2):335-345. doi: 10.1002/cpt.938. Epub 2017 Dec 6.

PMID:
29134633
50.

Good Manufacturing Practice (GMP) Translation of Advanced Cellular Therapeutics: Lessons for the Manufacture of Erythrocytes as Medicinal Products.

McGowan NWA, Campbell JDM, Mountford JC.

Methods Mol Biol. 2018;1698:285-292. doi: 10.1007/978-1-4939-7428-3_18. Review.

PMID:
29076098

Supplemental Content

Loading ...
Support Center